Congratulations to PhD student Mette Thrane Foged from NRU for recently winning a poster award at the "12th European Congress on Epileptology" which was held on September 11th-15th in Prague, Czech Republic.
On Friday September 23rd, NRU will be celebrating 20 years anniversary as independent research unit. The celebration will start at 2pm in Auditorium 2 at Rigshospitalet where there will be a 3-hour symposium with talks (in Danish) by current and previous NRU employees. The program for the symposium can be found below.
Gitte Moos Knudsen has recently received a grant worth 1.844 mio DKK from the The Danish Council for Independent Research - Medical Sciences for the project "In vivo assessment of novel pharmacological interventions in humans: An experimental medicine approach evaluating psilocybin and the serotonin 2A receptor". The project has a direct link to WP2 in NeuroPharm.
Congratulations to Cheng Teng Ip who has received an industrial PhD grant from the Innovation Fund Denmark for her project 'EEG and ERP biomarkers for prediction of antidepressant treatment response', which will be carried out together with H. Lundbeck A/S. The company covers 50% of Cheng's salary and she will be employed at the company for three years. The project is tightly connected to the NRU research in NeuroPharm, especially WP1, and Gitte Moos Knudsen will be project supervisor together with Søren Rahn Christensen who is Clinical Pharmacology Scientist at H. Lundbeck A/S.
Congratulations to Gitte Moos Knudsen and Matthias Herth who have been part of a successful proposal for the EU Joint Programme - Neurodegenerative Disease Research (JPND research) entitled "Framework for Innovative Multi-tracer molecular Brain Imaging (IMBI) to enable multi-centre trials and image evaluation in (early) neurodegenerative diseases". The proposal has received 49.900 € in funding for establishing an international working group with key experts from the field of PET imaging in neurodegenerative diseases (ND) with the aims:
Congratulations to Vincent, Sofi, Louise, Ling and Hanne for receiving travel support from 'Rigshospitalets Jubilæumsfond' for their participation at the NRM2016 in Boston, Vibeke for the ECNP2016 in Vienna, Patrick for OHBM2016 in Geneva and Liv for SLTBR2016 in New York. Gerda received funding from both Jubilæumsfonden and the Lundbeck Foundation for her participation at the SNMMI in San Diego.
A huge congratulation to NRU PhD student Sofi da Cunha-Bang who has Friday May 19th been honoured as the Younger Researcher of the Year (Årets Yngre Forsker 2016) at this year's poster and presentation competition arranged by the Collaboration of Young Researchers at Rigshospitalet (FYF). Sofi won the title based on her presentation on "High serotonin 1B receptor binding is associated with high trait anger and heightened amygdala and striatal reactiviy to provacations".
Congratulations to professor Jens D. Mikkelsen and senior researcher Vibe G. Frøkjær who have today received two separate grants totalling DKK 900.000 from the Augustinus Foundation.
Jens has received DKK 500.000 for a project entitled 'Neuromolekylære og kognitive effekter af en human-specifik alpha7 nicotinerg acetylcholin receptor variant' which is aiming at characterizing the expression, regulation and function of the CHRFAM7A gene in the human brain, and which will be run by senior researcher Henrik B. Hansen.
Vibe has received DKK 400.000 for the project 'Affective and Social Processing in Healthy Controls and Patients with Major Depressive Disorder; Implications for Predicting Response to Antidepressant Drug Therapy'. This neuropsychological project has a threefold aim, namely (1) to establish a healthy Danish reference group for the EMOTICOM test battery, (2) to determine the predictive value of EMOTICOM test outcomes in response to a pharmacological intervention in MDD patients and to determine if treatment induced changes in EMOTICOM test outcomes differentiates responders from non-responders, and (3) to identify a set of EMOTICOM test outcomes that best serves as diagnostic tools for differentiating MDD patients from a healthy Danish reference group. The project is tightly linked to the NeuroPharm Work Package 1 project 'Treatment outcome in Major Depressive Disorder'.